A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
Clinical trial NCT05652894 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05652894
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2026-06-30
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.